Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,065 public trials 1,848 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Active, not recruiting

A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)-Japan Extension

NCT06212752

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Fujita Health University ( Site 4406) Toyoake, Aichi-ken, Japan
  • Kurume University Hospital ( Site 4412) Kurume, Fukuoka, Japan
  • Gunma Prefectural Cancer Center ( Site 4416) Otashi, Gunma, Japan
  • National Hospital Organization Hokkaido Cancer Center ( Site 4415) Sapporo, Hokkaido, Japan
View all 18 locations
View Trial Details
Active, not recruiting

Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer

NCT00264602

Conditions
Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer

NCT03672773

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +9 more
Locations
  • CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • St. Joseph Heritage Healthcare Fullerton, California, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Orlando Health, Inc. d/b/a Orlando Health UF Health Center Orlando, Florida, United States
View Trial Details
Active, not recruiting

Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

NCT03539536

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • University of South Alabama /ID# 212939 Mobile, Alabama, United States
  • Mayo Clinic Arizona /ID# 218550 Phoenix, Arizona, United States
  • Highlands Oncology Group, PA /ID# 215600 Springdale, Arkansas, United States
  • University of California, Los Angeles /ID# 203219 Los Angeles, California, United States
View all 252 locations
View Trial Details
Active, not recruiting

Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening

NCT04968548

Conditions
Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations
  • Scripps Memorial Hospital Encinitas, California, United States
  • Centura Health Lakewood, Colorado, United States
  • VA Connecticut Healthcare System West Haven, Connecticut, United States
  • Orlando Health, Inc. Orlando, Florida, United States
View all 31 locations
View Trial Details
Active, not recruiting

Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

NCT06714617

Conditions
Adnexal Diseases, Breast Cancer Stage III, Breast Diseases, +48 more
Locations
  • SCRI-Denver HealthOne Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • SCRI-Florida Cancer Center Specialists Lake Mary Lake Mary, Florida, United States
  • Hematology Oncology Associates of the Treasure Cost Port Saint Lucie, Florida, United States
View Trial Details

Related conditions